Social network
Our responsibility


Sanofi’s internal program, “Transparency Initiative”, encompasses three main areas:

  • our interactions with healthcare providers (HCPs), healthcare organizations (HCOs) and medical and scientific associations (MSAs).
  • our interactions with patient associations. Collaborating with patient advocates and groups is a key lever toward access to healthcare, to enhance:
  • clinical trials data transparency. Making clinical trial information available to the public benefits patients, healthcare providers and the scientific community and is key to efficient scientific progress. Sanofi publicly shares information on appropriate clinical trials based on our commitments, international and local, legal and regulatory requirements, and other disclosure commitments established by the pharmaceutical industry associations of which we are a member.

Public disclosure in 40 countries of our interactions with healthcare professionals and medical & scientific associations